48,830
edits
Difference between revisions of "Vimentin"
Jump to navigation
Jump to search
no edit summary
| Line 6: | Line 6: | ||
*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal | last1 = Mısır | first1 = AF. | last2 = Durmuşlar | first2 = MC. | last3 = Zerener | first3 = T. | last4 = Gün | first4 = BD. | title = Primary malignant melanoma. | journal = Saudi Med J | volume = 37 | issue = 4 | pages = 446-9 | month = Apr | year = 2016 | doi = 10.15537/smj.2016.4.15017 | PMID = 27052289 }}</ref> | *[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal | last1 = Mısır | first1 = AF. | last2 = Durmuşlar | first2 = MC. | last3 = Zerener | first3 = T. | last4 = Gün | first4 = BD. | title = Primary malignant melanoma. | journal = Saudi Med J | volume = 37 | issue = 4 | pages = 446-9 | month = Apr | year = 2016 | doi = 10.15537/smj.2016.4.15017 | PMID = 27052289 }}</ref> | ||
===Vimentin and cytokeratin positivity=== | |||
Common tumours: | |||
*[[Renal cell carcinoma]].<ref name=pmid18318577/> | |||
*[[Endometrial carcinoma]].<ref name=pmid12647218/> | |||
*[[Ovarian serous carcinoma]].<ref name=pmid18318577>{{Cite journal | last1 = Bahrami | first1 = A. | last2 = Truong | first2 = LD. | last3 = Ro | first3 = JY. | title = Undifferentiated tumor: true identity by immunohistochemistry. | journal = Arch Pathol Lab Med | volume = 132 | issue = 3 | pages = 326-48 | month = Mar | year = 2008 | doi = 10.1043/1543-2165(2008)132[326:UTTIBI]2.0.CO;2 | PMID = 18318577 }}</ref> | |||
*[[Papillary thyroid carcinoma]].<ref name=pmid18318577/> | |||
*[[Sarcomatoid carcinoma]] (spindle cell carcinoma).<ref name=pmid18318577/> | |||
Rare tumours: | |||
*[[Synovial sarcoma]].<ref name=pmid15338724>{{cite journal |author=Llombart-Bosch A, Lopez-Guerrero JA, Peydro-Olaya A |title=Synovial sarcoma (SS): new perspectives supported by modern technology |journal=Arkh. Patol. |volume=64 |issue=3 |pages=39–47 |year=2002 |pmid=15338724 |doi= |url=}}</ref> | |||
*[[Rhabdoid tumour]].<ref name=pmid11557780>{{cite journal |author=Itakura E, Tamiya S, Morita K, ''et al.'' |title=Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence |journal=Mod. Pathol. |volume=14 |issue=9 |pages=854–61 |year=2001 |month=September |pmid=11557780 |doi=10.1038/modpathol.3880401 |url=http://www.nature.com/modpathol/journal/v14/n9/full/3880401a.html}}</ref> | |||
*[[Epithelioid sarcoma]].<ref name=pmid10452506>{{cite journal |author=Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, Fetsch JF |title=Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis |journal=Hum. Pathol. |volume=30 |issue=8 |pages=934–42 |year=1999 |month=August |pmid=10452506 |doi= |url=}}</ref> | |||
*[[Epithelioid angiosarcoma]].<ref name=pmid18318577/> | |||
*[[Desmoplastic small round cell tumour]].<ref name=pmid18318577/> | |||
*[[Anaplastic thyroid carcinoma]].<ref name=pmid18318577/> | |||
*Biphasic [[malignant mesothelioma]].<ref name=pmid18318577/> | |||
*[[Carcinosarcoma]].<ref name=pmid18318577/> | |||
Common tumours that uncommonly have the pattern: | |||
*[[Gastric adenocarcinoma]].<ref>URL: [http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165 http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165]. Accessed on: 26 April 2011.</ref> | |||
==Negative== | ==Negative== | ||
*Most [[carcinoma]]s. | *Most [[carcinoma]]s. | ||